Product Dossier
GLUCAGEN
Product Dossier for GLUCAGEN (Glucagon 1 mg, Novo Nordisk Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Novo Nordisk Pharmaceuticals
- Active ingredient: Glucagon 1 mg
- Therapeutic area: Endocrinology
- Same area: JANUMET
- Same area: LEVOXINE
What it is
GLUCAGEN HYPOKIT is a glucagon powder for injection vial with diluent syringe, containing 1 mg (1 IU) of glucagon.
Approved indications
The provided source documents do not contain information about the approved indications for GLUCAGEN.
Dosing overview
The provided source documents do not contain information about dosing recommendations for GLUCAGEN.
Key safety warnings
The provided source documents do not contain information about key safety warnings for GLUCAGEN.
Contraindications
The provided source documents do not contain information about contraindications for GLUCAGEN.
PBS listing
GLUCAGEN is listed on the PBS as an injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe. There are 3 PBS items with unrestricted access. The ex-manufacturer price is A$35.01.
Regulatory history
GLUCAGEN HYPOKIT was first registered on the ARTG on 28 February 1994.